Marta del Valle Rubido
Marta del Valle Rubido
Affiliazione sconosciuta
Email verificata su roche.com
Titolo
Citata da
Citata da
Anno
A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder
D Umbricht, M del Valle Rubido, E Hollander, JT McCracken, F Shic, ...
Neuropsychopharmacology 42 (9), 1914-1923, 2017
432017
Adaptive behavior in autism: Minimal clinically important differences on the Vineland‐II
CH Chatham, KI Taylor, T Charman, X Liogier D'Ardhuy, E Eule, A Fedele, ...
Autism Research 11 (2), 270-283, 2018
362018
A phase 2 clinical trial of a vasopressin V1a receptor antagonist shows improved adaptive behaviors in men with autism spectrum disorder
F Bolognani, M del Valle Rubido, L Squassante, C Wandel, M Derks, ...
Science translational medicine 11 (491), 2019
242019
In search of biomarkers for autism spectrum disorder
M Del Valle Rubido, JT McCracken, E Hollander, F Shic, J Noeldeke, ...
Autism research 11 (11), 1567-1579, 2018
142018
Safety and efficacy of different doses and regimens of faricimab vs ranibizumab in neovascular age-related macular degeneration: the AVENUE phase 2 randomized clinical trial
J Sahni, PU Dugel, SS Patel, ME Chittum, B Berger, M del Valle Rubido, ...
JAMA ophthalmology 138 (9), 955-963, 2020
42020
5.13 Effects of Balovaptan on Health-Related Quality of Life of Adult Men with ASD: Results from a Phase 2 Randomized Double-Blind Placebo Controlled Study (Vanilla)
L Squassante, F Bolognani, J Smith, L Murtagh, P Fontoura, O Khwaja, ...
Journal of the American Academy of Child & Adolescent Psychiatry 57 (10), S231, 2018
22018
The effects of a novel vasopressin V1a antagonist on orienting to biological motion
F Shic, M del Valle Rubido, E Hollander, SS Jeste, JT McCracken, ...
AGE 23, 5.1, 2014
22014
Exploring Social Biomarkers in High-Functioning Adults with Autism and Asperger’s Versus Healthy Controls: A Cross-Sectional Analysis
MDV Rubido, E Hollander, JT McCracken, F Shic, J Noeldeke, L Boak, ...
Journal of autism and developmental disorders 50 (12), 4412-4430, 2020
12020
A multi-center, observational study to explore the relationship between exploratory biomarkers and functional dimensions in adults with autistic spectrum disorders
MDV Rubido, E Hollander, J McCracken, F Shic, J Noeldeke, L Boak, ...
European Neuropsychopharmacology 2 (26), S193, 2016
2016
P. 7. d. 011 Results from a phase I proof-of-mechanism study with a vasopressin 1A receptor antagonist in autism spectrum disorder
MDV Rubido, D Umbricht, F Shic, JT McCracken, L Scahill, O Khwaja, ...
European Neuropsychopharmacology, S646-S647, 2015
2015
Olfaction is Associated with Ability to Recognize Emotions in High Functioning Autistic Subjects
D Umbricht, MV Rubido, F Shic, JT McCracken, L Scahill, O Khwaja, ...
NEUROPSYCHOPHARMACOLOGY 39, S584-S584, 2014
2014
Clinical and Biomarker Effects of a Novel Vasopressin 1a Receptor Antagonist (RG7713) vs. Placebo in High Functioning Adult Autism
E Hollander, M del Valle Rubido, O Khwaja, L Squassante, CJ Ferretti, ...
NEUROPSYCHOPHARMACOLOGY 39, S374-S375, 2014
2014
Affective Speech Recognition Clinical Biomarker Effects of a Novel Vasopressin 1a Receptor Antagonist Vs Placebo in Adult Autism
E Hollander, MV Rubido, O Khwaja, L Squassante, CJ Ferretti, BP Taylor, ...
BIOLOGICAL PSYCHIATRY 75 (9), 324S-325S, 2014
2014
Deficient Olfaction is Associated with Impaired Ability to Recognize Emotions in High Functioning Autistic Subjects and may be Improved by a Vasopressin 1a Receptor Antagonist
D Umbricht, MV Rubido, F Shik, JT McCracken, L Scahill, O Khwaja, ...
BIOLOGICAL PSYCHIATRY 75 (9), 388S-388S, 2014
2014
Orbiting-an Observational Study to Evaluate and Explore Scales for Restricted and Repetitive Behaviors and Digital Biomarkers in Children, Adolescents and Adults with Autism…
JF Hipp, E Eule, P Schoenenberger, T Ciobanu, T Kilchenmann, D Nobbs, ...
INSAR 2020 Virtual Meeting, 0
Use of Benzodiazepines in People with Autism Spectrum Disorder in the United States
S Roumpanis, M Johnson, C Liu, M del Valle Rubido
INSAR 2020 Virtual Meeting, 0
Results from a Phase I Proof-of-Mechanism Study with a Vasopressin 1a receptor antagonist in ASD
D Umbricht, M del Valle Rubido, F Shic, JT McCracken, L Scahill, ...
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–17